Psychiatry · Brooklyn, NY
NPI
1598760019
Since 2005
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1695 E 21st St, Apt A10
Brooklyn, NY, 11210
Phone (718) 252-3702
Medicare paid, 2024
$168K
2,260 services
Medicare patients, 2024
243
Average age 78
Drug cost, 2024
$1.9M
8,124 prescriptions
Company payments, 2025
$2,551
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna Potash was code 99442 (telephone services), 1,886 times for 231 patients. In total Anna Potash billed 2,260 services in 4 codes, and Medicare paid $168K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99442 Telephone Services | Office | 1,886 | 231 | $72.97 | $138K |
| 99213 Office E&M - Established | Office | 347 | 101 | $74.54 | $26K |
| 99205 Office E&M - New | Office | 25 | 25 | $175.56 | $4,389 |
By year: 2022 $172K for 2,016 services; 2023 $182K for 2,159 services; 2024 $168K for 2,260 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anna Potash prescribed most often to Medicare patients was Duloxetine Hcl, with 548 prescriptions and refills. In total Anna Potash wrote 8,124 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Duloxetine Hcl Generic | 548 | 578 | 52 | $4,803 |
| Trintellix Vortioxetine Hydrobromide | 524 | 531 | 57 | $250K |
| Zolpidem Tartrate Generic | 469 | 469 | 73 | $1,474 |
| Clonazepam Generic | 432 | 432 | 71 | $5,278 |
| Rexulti Brexpiprazole | 429 | 432 | 59 | $606K |
| Lorazepam Generic | 422 | 422 | 62 | $2,251 |
| Memantine Hcl Er Memantine Hcl | 305 | 308 | 34 | $18K |
| Lamotrigine Generic | 283 | 285 | 29 | $1,497 |
| Eszopiclone Generic | 276 | 276 | 38 | $4,766 |
| Aripiprazole Generic | 257 | 266 | 30 | $5,787 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 253 | 253 | 24 | $4,310 |
| Belsomra Suvorexant | 216 | 216 | 35 | $91K |
| Paroxetine Hcl Generic | 204 | 216 | 37 | $850 |
| Escitalopram Oxalate Generic | 203 | 212 | 26 | $670 |
| Alprazolam Generic | 198 | 198 | 24 | $1,156 |
Brand drugs: - claims; generic drugs: 6,056 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna Potash $2,551 ($2,551 in general payments such as food, travel and fees) from 11 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $612.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 22 | $612 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 16 | $415 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $360 |
| Axsome Therapeutics, Inc. AXSM | 8 | $329 |
| Alkermes, Inc. ALKS | 8 | $203 |
| Abbvie Inc. ABBV | 7 | $197 |
| Neurocrine BioSciences, Inc. NBIX | 6 | $172 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $149 |
| Almatica Pharma LLC | 2 | $53.71 |
| Bausch Health US, LLC BHC | 2 | $44.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.